ARTICLE | Company News
Bind Therapeutics, Navidea deal
June 29, 2015 7:00 AM UTC
Bind partnered non-exclusively with Navidea’s Macrophage Therapeutics subsidiary to develop tumor therapies that combine Bind’s Accurin therapeutic payload delivery nanoparticles with Macrophage’s Man...